Robert Caliph has been confirmed as the U.S. FDA Commissioner

In a narrow vote of 50-46 Duke University cardiologist Robert Calif was approved by the U.S. Senate as the next commissioner of the U.S. Food and Drug Administration (FDA). Several prominent Democrats voted against Caliph, while several Republicans supported him, resulting in a historically close vote. Caliph has sparked controversy among Democrats over his ties to the pharmaceutical industry – he previously worked for Verily Life Sciences, a parent company of Google, and served as a consultant for other pharmaceutical companies. The FDA has been without a permanent head since January 2021, at a time when COVID-19 led to the agency’s day-to-day operations under close public scrutiny. Caliph was nominated by President Joe Biden in November 2021. “Doctor. The caliph will bring vast scientific and practical experience to the FDA, ”said Mary Woolley, president of the research group Research! America. “It’s important for the FDA to have a Senate-approved leader to synthesize the lessons learned from COVID-19, take advantage of real evidence, and many other ways to keep up with rapidly evolving science.” Robert Caliph has been confirmed as the U.S. FDA Commissioner

Back to top button